CCM
EW icon

Covington Capital Management’s Edwards Lifesciences EW Stock Holding History

Covington Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$12.2M Buy
147,307
+3,745
+3% +$360K 0.53% 57
2022
Q2 		$13.7M Buy
143,562
+4,897
+4% +$507K 0.55% 52
2022
Q1 		$16.3M Buy
138,665
+24,209
+21% +$2.72M 0.59% 49
2021
Q4 		$14.8M Buy
114,456
+5,635
+5% +$657K 0.51% 59
2021
Q3 		$12.3M Buy
108,821
+6,436
+6% +$735K 0.47% 64
2021
Q2 		$10.6M Buy
102,385
+6,719
+7% +$633K 0.42% 74
2021
Q1 		$8M Buy
95,666
+19,649
+26% +$1.66M 0.34% 85
2020
Q4 		$6.93M Buy
76,017
+1,190
+2% +$98.7K 0.31% 91
2020
Q3 		$5.97M Sell
74,827
-4,560
-6% -$356K 0.3% 98
2020
Q2 		$5.49M Buy
79,387
+7,870
+11% +$559K 0.31% 90
2020
Q1 		$4.5M Sell
71,517
-1,743
-2% -$126K 0.3% 96
2019
Q4 		$5.7M Buy
73,260
+1,440
+2% +$112K 0.3% 98
2019
Q3 		$5.26M Buy
71,820
+5,940
+9% +$417K 0.3% 90
2019
Q2 		$4.06M Buy
65,880
+17,370
+36% +$1.05M 0.24% 107
2019
Q1 		$3.09M Sell
48,510
-1,110
-2% -$63.3K 0.19% 117
2018
Q4 		$2.53M Buy
49,620
+7,785
+19% +$394K 0.18% 122
2018
Q3 		$2.43M Buy
41,835
+4,680
+13% +$229K 0.15% 129
2018
Q2 		$1.8M Buy
37,155
+465
+1% +$21.7K 0.12% 143
2018
Q1 		$1.71M Sell
36,690
-789
-2% -$34.3K 0.11% 143
2017
Q4 		$1.41M Buy
37,479
+5,370
+17% +$197K 0.09% 159
2017
Q3 		$1.17M Buy
32,109
+2,160
+7% +$82.4K 0.08% 167
2017
Q2 		$1.18M Buy
29,949
+6,675
+29% +$244K 0.1% 144
2017
Q1 		$730K Buy
+23,274
New +$729K 0.06% 167

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Covington Capital Management's EW Position: Q3 2022 in Review

Covington Capital Management increased its Edwards Lifesciences (EW) stake by 2.6% in Q3 2022, buying an estimated $360K and bringing the position to 147,307 shares worth $12.2M. The position accounts for 0.53% of the portfolio, ranked #57.

Covington Capital Management first reported a position in EW in Q1 2017 and has held it in 23 quarters since. The position peaked at $16.3M in Q1 2022. 1,247 funds tracked by Wall St. Rank hold EW as of Q3 2022.

  • Covington Capital Management held 147,307 shares of Edwards Lifesciences worth $12.2M as of Q3 2022.
  • Covington Capital Management bought 3,745 Edwards Lifesciences shares in Q3 2022, an estimated $360K.
  • Edwards Lifesciences made up 0.53% of Covington Capital Management's portfolio in Q3 2022, its #57 holding.
  • Covington Capital Management first reported a position in Edwards Lifesciences in Q1 2017 and has held it in 23 quarters since.
  • Covington Capital Management's Edwards Lifesciences position peaked at $16.3M in Q1 2022.
  • 1,247 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2022.

Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.